Rushton et al., 2021 - Google Patents
A review of circulating tumour cell enrichment technologiesRushton et al., 2021
View HTML- Document ID
- 3711718484352923000
- Author
- Rushton A
- Nteliopoulos G
- Shaw J
- Coombes R
- Publication year
- Publication venue
- Cancers
External Links
Snippet
Simple Summary Circulating tumour cells (CTCs) are cancer cells shed into the bloodstream from tumours and their analysis can provide important insights into cancer detection and monitoring, with the potential to direct personalised therapies for the patient. These CTCs …
- 210000004027 cells 0 abstract description 233
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rushton et al. | A review of circulating tumour cell enrichment technologies | |
Kulasinghe et al. | The use of microfluidic technology for cancer applications and liquid biopsy | |
Bankó et al. | Technologies for circulating tumor cell separation from whole blood | |
Akpe et al. | Circulating tumour cells: a broad perspective | |
Marrugo-Ramírez et al. | Blood-based cancer biomarkers in liquid biopsy: a promising non-invasive alternative to tissue biopsy | |
Descamps et al. | Microfluidic-based technologies for CTC isolation: a review of 10 years of intense efforts towards liquid biopsy | |
Zeinali et al. | High-throughput label-free isolation of heterogeneous circulating tumor cells and CTC clusters from non-small-cell lung cancer patients | |
Bailey et al. | Insights on CTC biology and clinical impact emerging from advances in capture technology | |
Campbell et al. | Microfluidic and paper-based devices for disease detection and diagnostic research | |
Witek et al. | Cell separations and sorting | |
Lee et al. | All-in-one centrifugal microfluidic device for size-selective circulating tumor cell isolation with high purity | |
Low et al. | Benchtop technologies for circulating tumor cells separation based on biophysical properties | |
Gwak et al. | Progress in circulating tumor cell research using microfluidic devices | |
Yang et al. | Circulating tumor cells from enumeration to analysis: Current challenges and future opportunities | |
Ren et al. | Entrapment of prostate cancer circulating tumor cells with a sequential size-based microfluidic chip | |
Carmona-Ule et al. | Short-term ex vivo culture of CTCs from advance breast cancer patients: clinical implications | |
Yoon et al. | Continuous separation of circulating tumor cells from whole blood using a slanted weir microfluidic device | |
Lei | A review on microdevices for isolating circulating tumor cells | |
Tadimety et al. | Liquid biopsy on chip: a paradigm shift towards the understanding of cancer metastasis | |
Kang et al. | Evaluation of positive and negative methods for isolation of circulating tumor cells by lateral magnetophoresis | |
Kalyan et al. | Inertial microfluidics enabling clinical research | |
Tseng et al. | Dynamic changes in numbers and properties of circulating tumor cells and their potential applications | |
Bhat et al. | Recent advances in microfluidic platform for physical and immunological detection and capture of circulating tumor cells | |
Budna-Tukan et al. | Analysis of circulating tumor cells in patients with non-metastatic high-risk prostate cancer before and after radiotherapy using three different enumeration assays | |
Kitz et al. | Circulating tumor cell analysis in preclinical mouse models of metastasis |